BCAN Think Tank session 2: Molecular detection of bladder cancer: The path to progress

Victoria L. Robinson, Michael Porter, Edward Messing, Yves Fradet, Ashish M. Kamat, Yair Lotan

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Initial detection of bladder cancer and surveillance for cancer recurrence and progression are central topics in the field of urologic oncology. A session at the 3rd Annual Bladder Cancer Think Tank Meeting focused on urine-based markers for bladder cancer screening and surveillance. Here, we review the key points from the presentations, as well as the recommendations from a working group tasked with critically evaluating the information discussed in the session. Although the practicality of markers has been challenged, the resounding consensus was that continued research efforts directed at developing and evaluating markers for screening and early detection are warranted.

Original languageEnglish (US)
Pages (from-to)334-337
Number of pages4
JournalUrologic Oncology: Seminars and Original Investigations
Volume28
Issue number3
DOIs
StatePublished - May 2010

Fingerprint

Urinary Bladder Neoplasms
Early Detection of Cancer
Urine
Recurrence
Research
Neoplasms

Keywords

  • Bladder cancer
  • Urine-based markers

ASJC Scopus subject areas

  • Oncology
  • Urology

Cite this

BCAN Think Tank session 2 : Molecular detection of bladder cancer: The path to progress. / Robinson, Victoria L.; Porter, Michael; Messing, Edward; Fradet, Yves; Kamat, Ashish M.; Lotan, Yair.

In: Urologic Oncology: Seminars and Original Investigations, Vol. 28, No. 3, 05.2010, p. 334-337.

Research output: Contribution to journalArticle

Robinson, Victoria L. ; Porter, Michael ; Messing, Edward ; Fradet, Yves ; Kamat, Ashish M. ; Lotan, Yair. / BCAN Think Tank session 2 : Molecular detection of bladder cancer: The path to progress. In: Urologic Oncology: Seminars and Original Investigations. 2010 ; Vol. 28, No. 3. pp. 334-337.
@article{311584d731854db98b18498fdd976eb2,
title = "BCAN Think Tank session 2: Molecular detection of bladder cancer: The path to progress",
abstract = "Initial detection of bladder cancer and surveillance for cancer recurrence and progression are central topics in the field of urologic oncology. A session at the 3rd Annual Bladder Cancer Think Tank Meeting focused on urine-based markers for bladder cancer screening and surveillance. Here, we review the key points from the presentations, as well as the recommendations from a working group tasked with critically evaluating the information discussed in the session. Although the practicality of markers has been challenged, the resounding consensus was that continued research efforts directed at developing and evaluating markers for screening and early detection are warranted.",
keywords = "Bladder cancer, Urine-based markers",
author = "Robinson, {Victoria L.} and Michael Porter and Edward Messing and Yves Fradet and Kamat, {Ashish M.} and Yair Lotan",
year = "2010",
month = "5",
doi = "10.1016/j.urolonc.2009.07.026",
language = "English (US)",
volume = "28",
pages = "334--337",
journal = "Urologic Oncology: Seminars and Original Investigations",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "3",

}

TY - JOUR

T1 - BCAN Think Tank session 2

T2 - Molecular detection of bladder cancer: The path to progress

AU - Robinson, Victoria L.

AU - Porter, Michael

AU - Messing, Edward

AU - Fradet, Yves

AU - Kamat, Ashish M.

AU - Lotan, Yair

PY - 2010/5

Y1 - 2010/5

N2 - Initial detection of bladder cancer and surveillance for cancer recurrence and progression are central topics in the field of urologic oncology. A session at the 3rd Annual Bladder Cancer Think Tank Meeting focused on urine-based markers for bladder cancer screening and surveillance. Here, we review the key points from the presentations, as well as the recommendations from a working group tasked with critically evaluating the information discussed in the session. Although the practicality of markers has been challenged, the resounding consensus was that continued research efforts directed at developing and evaluating markers for screening and early detection are warranted.

AB - Initial detection of bladder cancer and surveillance for cancer recurrence and progression are central topics in the field of urologic oncology. A session at the 3rd Annual Bladder Cancer Think Tank Meeting focused on urine-based markers for bladder cancer screening and surveillance. Here, we review the key points from the presentations, as well as the recommendations from a working group tasked with critically evaluating the information discussed in the session. Although the practicality of markers has been challenged, the resounding consensus was that continued research efforts directed at developing and evaluating markers for screening and early detection are warranted.

KW - Bladder cancer

KW - Urine-based markers

UR - http://www.scopus.com/inward/record.url?scp=77951597990&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77951597990&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2009.07.026

DO - 10.1016/j.urolonc.2009.07.026

M3 - Article

C2 - 20439033

AN - SCOPUS:77951597990

VL - 28

SP - 334

EP - 337

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

SN - 1078-1439

IS - 3

ER -